Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3335716 | Transfusion and Apheresis Science | 2010 | 4 Pages |
Abstract
We aimed to describe the characteristics, treatment regime, and 6-month all-cause mortality of thrombotic thrombocytopenic purpura (TTP) patients treated with total plasma exchange in the our clinic. Thirteen patients were included in the study. Mortality rates of TTP have improved over the last three decades but they are still too high according to modern therapy expectations. Etiology directed treatment should be added to total plasma exchange in secondary TTP cases. Based on TTPs' immunologic etiology, immune modulator and immune suppressor agents have been applied together with total plasma exchange, but mostly in anecdotal case reports or with questionable responses.
Related Topics
Health Sciences
Medicine and Dentistry
Hematology
Authors
Rahsan Yildirim, Yusuf Bilen, Mustafa Keles, Abdullah Uyanik, Fatih Albayrak, Fuat Erdem, İlhami Kiki, Ramazan Cetinkaya, Mehmet Gundogdu,